Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Stakeholder Letter Asking Congress Renew Efforts on CLIA Reform and Urge FDA to Halt LDT Rulemaking
-
Sign-on Letter Supporting Draft Legislation Addressing Budget Neutrality Impact to Physician Payment Rates
-
Letter to FDA Requesting Extension of Comment Period for Proposed Rule on Regulation of LDTs
-
ACMG Request to FDA to Extend Comment Period for Proposed Rule on Regulation of LDTs
-
ACMG Comments on CY 2024 Physician Fee Schedule Proposed Rule
-
Sign-on Letter Regarding the Novitas & FCSO Proposed LCD on Genetic Testing for Oncology
-
ACMG & ABMGG Joint Response to Supreme Court Ruling on Affirmative Action
-
ACMG Response to NYS on Proposed Changes to Onsite Work Requirements for Lab Directors
-
ACMG Comments to the CLIAC Regarding Remote Laboratory Work